These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35430635)

  • 41. Five-year efficacy of pulmonary vein antrum isolation as a primary ablation strategy for atrial fibrillation: a single-centre cohort study.
    Teunissen C; Kassenberg W; van der Heijden JF; Hassink RJ; van Driel VJ; Zuithoff NP; Doevendans PA; Loh P
    Europace; 2016 Sep; 18(9):1335-42. PubMed ID: 26838694
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High-power short duration vs. conventional radiofrequency ablation of atrial fibrillation: a systematic review and meta-analysis.
    Ravi V; Poudyal A; Abid QU; Larsen T; Krishnan K; Sharma PS; Trohman RG; Huang HD
    Europace; 2021 May; 23(5):710-721. PubMed ID: 33523184
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Network meta-analysis and systematic review comparing efficacy and safety between very high power short duration, high power short duration, and conventional radiofrequency ablation of atrial fibrillation.
    Tokavanich N; Prasitlumkum N; Kewcharoen J; Chokesuwattanaskul R; Phannajit J; Cheungpasitporn W; Akoum N; Ranjan R; Bunch TJ; Navaravong L
    J Cardiovasc Electrophysiol; 2023 Apr; 34(4):869-879. PubMed ID: 36691892
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Safety and Efficacy of High Power Shorter Duration Ablation Guided by Ablation Index or Lesion Size Index in Atrial Fibrillation Ablation: A Systematic Review and Meta-Analysis.
    Liu X; Gui C; Wen W; He Y; Dai W; Zhong G
    J Interv Cardiol; 2021; 2021():5591590. PubMed ID: 34149322
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pulmonary vein isolation using a higher power shorter duration CLOSE protocol with a surround flow ablation catheter.
    Berte B; Hilfiker G; Russi I; Moccetti F; Cuculi F; Toggweiler S; Ruschitzka F; Kobza R
    J Cardiovasc Electrophysiol; 2019 Nov; 30(11):2199-2204. PubMed ID: 31424123
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Left atrial volumetry from routine diagnostic work up prior to pulmonary vein ablation is a good predictor of freedom from atrial fibrillation.
    Sohns C; Sohns JM; Vollmann D; Lüthje L; Bergau L; Dorenkamp M; Zwaka PA; Hasenfuß G; Lotz J; Zabel M
    Eur Heart J Cardiovasc Imaging; 2013 Jul; 14(7):684-91. PubMed ID: 23435593
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Safety and efficacy of high power shorter duration ablation for atrial fibrillation: A systematic review and meta-analysis.
    Li MF; Wu J; Jin CL; Chen CF; Xu YZ
    Int J Clin Pract; 2021 Apr; 75(4):e13732. PubMed ID: 32975347
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy of high-power and short-duration ablation in patients with atrial fibrillation: a prospective randomized controlled trial.
    Shin DG; Ahn J; Han SJ; Lim HE
    Europace; 2020 Oct; 22(10):1495-1501. PubMed ID: 32810203
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relationship between contact force sensing technology and medium-term outcome of atrial fibrillation ablation: a multicenter study of 600 patients.
    Jarman JWE; Panikker S; DAS M; Wynn GJ; Ullah W; Kontogeorgis A; Haldar SK; Patel PJ; Hussain W; Markides V; Gupta D; Schilling RJ; Wong T
    J Cardiovasc Electrophysiol; 2015 Apr; 26(4):378-384. PubMed ID: 25546580
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of weight adjusted high frequency low tidal volume ventilation and atrial pacing in lesion metrics in high-power short-duration ablation: Results of a pilot study.
    Vassallo F; Volponi C; Cunha C; Corcino L; Serpa E; Simoes A; Gasparini D; Barbosa LF; Schmidt A
    J Cardiovasc Electrophysiol; 2024 May; 35(5):975-983. PubMed ID: 38482937
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Left atrial strain is a powerful predictor of atrial fibrillation recurrence after catheter ablation: study of a heterogeneous population with sinus rhythm or atrial fibrillation.
    Yasuda R; Murata M; Roberts R; Tokuda H; Minakata Y; Suzuki K; Tsuruta H; Kimura T; Nishiyama N; Fukumoto K; Aizawa Y; Tanimoto K; Takatsuki S; Abe T; Fukuda K
    Eur Heart J Cardiovasc Imaging; 2015 Sep; 16(9):1008-14. PubMed ID: 25750193
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Feasibility and safety of high-power ablation of atrial fibrillation with contact force-sensing catheter: The lesion size index-guided ablation.
    Parwani AS; Hohendanner F; Kluck A; Blaschke F; Pieske B; Boldt LH
    Adv Clin Exp Med; 2022 Jul; 31(7):715-721. PubMed ID: 35302302
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Functional disconnection of arrhythmogenic pulmonary veins in patients with paroxysmal atrial fibrillation guided by combined electroanatomical (CARTO) and conventional mapping.
    Weiss C; Willems S; Risius T; Hoffmann M; Ventura R; Meinertz T
    J Interv Card Electrophysiol; 2002 Jul; 6(3):267-75. PubMed ID: 12154329
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Post-ablation left atrial function impacts long-term recurrence of atrial fibrillation after ablation.
    Oka T; Koyama Y; Tanaka K; Hirao Y; Tanaka N; Okada M; Yoshimoto I; Kitagaki R; Okamura A; Iwakura K; Sakata Y; Fujii K; Inoue K
    Heart Vessels; 2022 Feb; 37(2):315-326. PubMed ID: 34342674
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Randomized Study of Persistent Atrial Fibrillation Ablation: Ablate in Sinus Rhythm Versus Ablate Complex-Fractionated Atrial Electrograms in Atrial Fibrillation.
    Bassiouny M; Saliba W; Hussein A; Rickard J; Diab M; Aman W; Dresing T; Callahan T; Bhargava M; Martin DO; Shao M; Baranowski B; Tarakji K; Tchou PJ; Hakim A; Kanj M; Lindsay B; Wazni O
    Circ Arrhythm Electrophysiol; 2016 Feb; 9(2):e003596. PubMed ID: 26857909
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Impact of Pulmonary Vein Anatomy on the Outcomes of Catheter Ablation for Atrial Fibrillation.
    Istratoaie S; Roșu R; Cismaru G; Vesa ȘC; Puiu M; Zdrenghea D; Pop D; Buzoianu AD
    Medicina (Kaunas); 2019 Nov; 55(11):. PubMed ID: 31690031
    [No Abstract]   [Full Text] [Related]  

  • 57. Tailored atrial substrate modification based on low-voltage areas in catheter ablation of atrial fibrillation.
    Rolf S; Kircher S; Arya A; Eitel C; Sommer P; Richter S; Gaspar T; Bollmann A; Altmann D; Piedra C; Hindricks G; Piorkowski C
    Circ Arrhythm Electrophysiol; 2014 Oct; 7(5):825-33. PubMed ID: 25151631
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Isolation of the posterior left atrium for patients with persistent atrial fibrillation: routine adenosine challenge for dormant posterior left atrial conduction improves long-term outcome.
    McLellan AJA; Prabhu S; Voskoboinik A; Wong MCG; Walters TE; Pathik B; Morris GM; Nisbet A; Lee G; Morton JB; Kalman JM; Kistler PM
    Europace; 2017 Dec; 19(12):1958-1966. PubMed ID: 28204434
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of Effectiveness and Safety between High-Power Short-Duration Ablation and Conventional Ablation for Atrial Fibrillation: A Systematic Review and Meta-Analysis.
    Jin S; Fu L; Jiang J; Ye X; Liu H; Chen Y; Pu S; Wu S; Xue Y
    J Interv Cardiol; 2022; 2022():6013474. PubMed ID: 36072362
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vivo tissue temperatures during 90 W/4 sec-very high power-short-duration (vHPSD) ablation versus ablation index-guided 50 W-HPSD ablation: A porcine study.
    Otsuka N; Okumura Y; Kuorkawa S; Nagashima K; Wakamatsu Y; Hayashida S; Ohkubo K; Nakai T; Hao H; Takahashi R; Taniguchi Y
    J Cardiovasc Electrophysiol; 2023 Feb; 34(2):369-378. PubMed ID: 36527433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.